Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation

Raloxifene HCl belongs to a class of selective estrogen receptor modulators (SERMs) which is used for the management of breast cancer. The major problem reported with raloxifene is its poor bioavailability which is only up to 2%. The main objective of the present work was to formulate raloxifene loa...

Full description

Bibliographic Details

Main Authors:	Mahmood, Syed, Mandal, Uttam K., Chatterjee, Bappaditya
Format:	Article
Language:	en en
Published:	Elsevier B.V. 2018
Subjects:	RS Pharmacy and materia medica
Online Access:	http://umpir.ump.edu.my/id/eprint/20675/1/Transdermal%20delivery%20of%20raloxifene%20HCl%20via%20ethosomal%20system_%20Formulation%2C%20advanced%20characterizations%20and%20pharmacokinetic%20evaluation.pdf http://umpir.ump.edu.my/id/eprint/20675/7/Transdermal%20delivery%20of%20raloxifene%20HCl%20via%20ethosomal%20system.%20Formulation%2Cadvanced%20characterizations%20and%20pharmacokinetic%20evaluation.pdf http://umpir.ump.edu.my/id/eprint/20675/ https://doi.org/10.1016/j.ijpharm.2018.02.044
Tags:	Add Tag No Tags, Be the first to tag this record!